ZBIO
Zenas BioPharma, Inc. Common Stock
NASDAQ: ZBIO · HEALTHCARE · BIOTECHNOLOGY
$17.55
-2.55% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
—
P/S ratio
109.46x
EPS (TTM)
$-8.44
Dividend yield
—
52W range
$9 – $45
Volume
0.7M
Zenas BioPharma, Inc. Common Stock (ZBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $74.58M | $68.18M | $369.97M |
| Cash & equivalents | $67.21M | $56.86M | $319.74M |
| Current assets | $68.44M | $59.80M | $355.92M |
| Total liabilities | $266.87M | $293.90M | $57.51M |
| Current liabilities | $25.97M | $23.26M | $57.29M |
| Long-term debt | — | $20.30M | — |
| Shareholder equity | $-192.29M | $-225.72M | $312.46M |
| Retained earnings | $-193.28M | $-230.40M | $-387.39M |
| Accounts receivable | — | — | — |
| Inventory | — | — | — |
| Goodwill | — | — | — |